deltatrials
Suspended NA INTERVENTIONAL 2-arm NCT00566514

The Role of Ribose in Patients Diagnosed With Fibromyalgia

The Role of D-RIbose in Patients Diagnosed With Fibromyalgia

Sponsor: Bioenergy Life Science, Inc.

Conditions Fibromyalgia
Interventions D-ribose dextrose
Updated 5 times since 2017 Last updated: Mar 10, 2008 Started: Jul 31, 2006 Primary completion: Jul 31, 2008 Completion: Jul 31, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Protocol Under Review

This NA trial investigates Fibromyalgia and is currently suspended. Bioenergy Life Science, Inc. leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotSuspended~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotSuspended~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotSuspended~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotSuspended~Sep 2024 – present · 24 months · monthly snapshotSuspended

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Suspended NA

  2. Jul 2024 — Sep 2024 [monthly]

    Suspended NA

  3. Jan 2021 — Jul 2024 [monthly]

    Suspended NA

  4. Jun 2018 — Jan 2021 [monthly]

    Suspended NA

  5. Jan 2017 — Jun 2018 [monthly]

    Suspended NA

    First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bioenergy Life Science, Inc.
Data source: Bioenergy Life Science, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations